FI861559A - Menetelmä hepatitis B-viruksen pinta-antigeenin PreS1-PreS2-S-proteiinin koodaavan alueen koodaamia proteiineja käsittävän proteiinin valmistamiseksi sekä menetelmässä käytettävät yhdistelmä-DNA-vektorit ja -kontameerit sekä nisäkässolut - Google Patents
Menetelmä hepatitis B-viruksen pinta-antigeenin PreS1-PreS2-S-proteiinin koodaavan alueen koodaamia proteiineja käsittävän proteiinin valmistamiseksi sekä menetelmässä käytettävät yhdistelmä-DNA-vektorit ja -kontameerit sekä nisäkässolut Download PDFInfo
- Publication number
- FI861559A FI861559A FI861559A FI861559A FI861559A FI 861559 A FI861559 A FI 861559A FI 861559 A FI861559 A FI 861559A FI 861559 A FI861559 A FI 861559A FI 861559 A FI861559 A FI 861559A
- Authority
- FI
- Finland
- Prior art keywords
- protein
- pres1
- pres2
- coding region
- hepatitis
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title 3
- 108090000623 proteins and genes Proteins 0.000 title 3
- 108091026890 Coding region Proteins 0.000 title 1
- 241000700721 Hepatitis B virus Species 0.000 title 1
- 108020004511 Recombinant DNA Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 239000000356 contaminant Substances 0.000 title 1
- 210000004962 mammalian cell Anatomy 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
- 108700026244 Open Reading Frames Proteins 0.000 abstract 2
- 101710132601 Capsid protein Proteins 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 210000003527 eukaryotic cell Anatomy 0.000 abstract 1
- 208000002672 hepatitis B Diseases 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000001890 transfection Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
- G01N33/5764—Hepatitis B surface antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI914267A FI95726C (fi) | 1985-04-15 | 1991-09-10 | Diagnostiset menetelmät ja määrityssarjat, joissa käytetään yhdistelmä-DNA-tekniikalla muodostettua hepatitis B -viruksen pinta-antigeenia |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP85104521 | 1985-04-15 | ||
| EP85104521 | 1985-04-15 | ||
| US85056786A | 1986-04-11 | 1986-04-11 | |
| US85056786 | 1986-04-11 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI861559A0 FI861559A0 (fi) | 1986-04-14 |
| FI861559A true FI861559A (fi) | 1986-10-16 |
| FI95045B FI95045B (fi) | 1995-08-31 |
| FI95045C FI95045C (fi) | 1995-12-11 |
Family
ID=26096680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI861559A FI95045C (fi) | 1985-04-15 | 1986-04-14 | Menetelmä hepatitis B-viruksen pinta-antigeenin PreS1-PreS2-S-proteiinin koodaavan alueen koodaamia proteiineja käsittävän proteiinin valmistamiseksi sekä menetelmässä käytettävät yhdistelmä-DNA-vektorit ja -kontameerit sekä nisäkässolut |
Country Status (9)
| Country | Link |
|---|---|
| KR (1) | KR960004264B1 (fi) |
| AU (1) | AU606574B2 (fi) |
| DK (1) | DK171386A (fi) |
| FI (1) | FI95045C (fi) |
| HU (1) | HUT40699A (fi) |
| NO (1) | NO861450L (fi) |
| NZ (1) | NZ215820A (fi) |
| OA (1) | OA08238A (fi) |
| PT (1) | PT82392B (fi) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU619753B2 (en) * | 1987-06-22 | 1992-02-06 | Medeva Holdings B.V. | Hepatitis b surface antigen vaccine |
-
1986
- 1986-04-14 FI FI861559A patent/FI95045C/fi not_active IP Right Cessation
- 1986-04-14 NZ NZ215820A patent/NZ215820A/xx unknown
- 1986-04-14 NO NO861450A patent/NO861450L/no unknown
- 1986-04-15 AU AU56114/86A patent/AU606574B2/en not_active Ceased
- 1986-04-15 DK DK171386A patent/DK171386A/da not_active Application Discontinuation
- 1986-04-15 PT PT82392A patent/PT82392B/pt not_active IP Right Cessation
- 1986-04-15 KR KR1019860002859A patent/KR960004264B1/ko not_active IP Right Cessation
- 1986-04-15 OA OA58835A patent/OA08238A/xx unknown
- 1986-04-15 HU HU861577A patent/HUT40699A/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT82392A (en) | 1986-05-01 |
| AU5611486A (en) | 1986-10-23 |
| DK171386A (da) | 1986-10-16 |
| NZ215820A (en) | 1989-01-06 |
| HUT40699A (en) | 1987-01-28 |
| DK171386D0 (da) | 1986-04-15 |
| AU606574B2 (en) | 1991-02-14 |
| FI95045C (fi) | 1995-12-11 |
| KR860008284A (ko) | 1986-11-14 |
| KR960004264B1 (ko) | 1996-03-30 |
| OA08238A (en) | 1987-10-30 |
| NO861450L (no) | 1986-10-16 |
| FI861559A0 (fi) | 1986-04-14 |
| FI95045B (fi) | 1995-08-31 |
| PT82392B (pt) | 1988-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP8600035A0 (en) | Hepatitis B surface antigen formed by recombinant DNA Techniques, vaccines, diagnostics, cell lines and methods of forming same. | |
| IL87737A (en) | Method for culturing polypeptide factor dependent vertebrate recombinant cells | |
| GB2197324B (en) | Process for the production of a polypeptide | |
| IL87255A0 (en) | Dna constructs containing a kluyveromyces alphafactor leader sequence for directing secretion of heterologous polypeptides | |
| KR910004803A (ko) | 간의 실질 세포 성장 인자, 이를 코딩하는 유전자, 이 인자를 생산하는 방법, 및 이 인자를 생산하는 형질전환체 | |
| DE69839553D1 (de) | Verfahren zur herstellung von proteinen | |
| EP0106828A3 (en) | Recombinant dna molecules encoding for hepatitis b surface antigen, their preparation and derived vaccines | |
| FI861559A (fi) | Menetelmä hepatitis B-viruksen pinta-antigeenin PreS1-PreS2-S-proteiinin koodaavan alueen koodaamia proteiineja käsittävän proteiinin valmistamiseksi sekä menetelmässä käytettävät yhdistelmä-DNA-vektorit ja -kontameerit sekä nisäkässolut | |
| ES2080759T3 (es) | Produccion de proteinas o polipeptidos fusionados. | |
| ATE136057T1 (de) | Autonom replizierende dna fragmente aus säugerzellen mit affinität zu dna bindenden proteinen | |
| EP0422217A4 (en) | Human recombinant placental ribonuclease inhibitor and method of production | |
| GB2229184B (en) | A gene coding for glucuronide permease | |
| DE3877136D1 (de) | Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung. | |
| ATE335005T1 (de) | Menschliches protein mit in vitro antiproliferativer aktivität. | |
| NZ511303A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same with homology to Hep27 protein | |
| ATE268819T1 (de) | Pro241 polypeptide und dafür kodierende nukleinsäuren | |
| SU1380209A1 (ru) | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed |
Owner name: ENDOTRONICS, INC. |